- 101. cinnamate
- [ ] (UMLS (CSP) C0008801) =Organic Chemical =Acids, Carbocyclic;
=2-ethylhexyl-4-methoxycinnamate;
Giv-Tan F;
| - 151. Circumscribed Storiform Collagenoma
- (UMLS (NCI) C0406815) =Neoplastic Process
|
- 102. CINNAMON
- [The dried inner bark of the Cinnamon tree is used medicinally and in SPICES. ( MSH )] (UMLS (NCI) C1112857) =Food ;
| - 152. circumsporozoite protein
- [protein found in various species of Plasmodium; investigated for malaria vaccine development. ( CSP )] (UMLS (CSP) C0055782) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=gene product;
|
- 103. CINOXACIN
- [Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS. ( MSH )] (UMLS (NCI) C0008806) =Organic Chemical; Pharmacologic Substance =Acids, Heterocyclic;
Heterocyclic Compounds, 3-Ring;
[AM900] ANTI-INFECTIVES, OTHER;
=CINOXACIN 250 MG;
CINOXACIN 500 MG;
| - 153. Circumvallate Papilla
- [One of eight or ten projections from the dorsum of the tongue forming a row anterior to and parallel with the sulcus terminalis; each papilla is surrounded by a circular trench (fossa) having a slightly raised outer wall (vallum); on the sides of the vallate papilla and the opposed margin of the vallum are numerous taste buds. ( NCI )] (UMLS (NCI) C1182961) Vallate Papilla =Body Part, Organ, or Organ Component
|
- 104. Ciprinol
- [ ] (UMLS (CSP) C0701043) =Organic Chemical; Pharmacologic Substance ;
| - 154. cirrhosis
- [liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. ( CSP )] (UMLS (NCI) C0023890) =Disease or Syndrome ;
=Hepatic Disorder;
=ALCOHOL CIRRHOSIS LIVER;
BILIARY CIRRHOSIS;
Liver Cirrhosis, Experimental;
|
- 105. Cipro
- (UMLS (NCI) C0701042) =Organic Chemical; Pharmacologic Substance ;
| - 155. CIRRHOSIS OF LIVER NOS
- (UMLS (ICD9CM) C0008827) =Disease or Syndrome ;
|
- 106. Ciprofloxacin/Dexamethasone/Pentoxifylline
- (UMLS (NCI) C0678082) =Therapeutic or Preventive Procedure ;
| - 156. Cirrhosis/other liver disease
- (UMLS (ICPC) C0497198) (Cirrhosis/other liver disease; ZIRROSIS/GIBELEKO BESTE ERITASUN BAT; Levercirrose/anden leversygdom; Cirrose/andere leverziekten; KIRROOSI/MUU MAKSASAIRAUS; Cirrhoses/autres maladies du foie; Zirrhose/sonstige Lebererkrankung; tzirozis shel hakaved; cirrhosis/egyeb maj-megbet.; Cirrosi/altre malattie epatiche; SKRUMPLEVER/ANDRE LEVERSYKDOMMER; Cirrose/outras doencas hepaticas; Cirrosis/otras enf hepaticas; SKRUMPLEVER/ANNAN LEVERSJUKDOM) =Disease or Syndrome =Body System, Gastrointestinal; Diagnosis/Diseases Component
|
- 107. Ciramadol Hydrochloride
- (UMLS (NCI) C0890132) =Organic Chemical; Pharmacologic Substance
| - 157. Cirripedia
- [marine; adults attach to hard objects in the water; body usually enclosed in a shell. ( CSP )] (UMLS (CSP) C1095841) =Invertebrate ;
=Crustacea;
|
- 108. CIRCADIAN RHY-ADVC SLEEP
- [ ] (UMLS (ICD9CM) C1561873) Circadian rhythm sleep disorder, advanced sleep phase type;
=Disease or Syndrome | - 158. CIS
- [Cytokine Inducible SH2-Containing Protein, encoded by the human CISH gene, is a cytokine-inducible negative regulator of cytokine signaling. This protein contains a SH2 domain and a SOCS box domain. The expression of this gene can be induced by IL2, IL3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein is involved in the inactivation of the erythropoietin receptor. Association with EPOR may target this protein for proteolysis by the ubiquitin-dependent proteasome pathway. The CISH protein is mainly monoubiquitinated (37 kD) but may also exist in a polyubiquitinated form (45 kD). Three isoforms (1, 1B, 1C) are produced by alternative splicing, and the tissue distribution of isoforms 1 and 1B is distinct. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0299250) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 109. CIRCADIAN RHY-DELAY SLP
- [ ] (UMLS (ICD9CM) C1561872) Circadian rhythm sleep disorder, delayed sleep phase type;
=Disease or Syndrome | - 159. cis acting element
- [ ] (UMLS (CSP) C0599780) =Nucleotide Sequence ;
|
- 110. CIRCADIAN RHY-SHIFT WORK
- [ ] (UMLS (ICD9CM) C1561877) Circadian rhythm sleep disorder, shift work type;
=Disease or Syndrome | - 160. CIS Family Gene
- [Suppressor of Cytokine Signaling (SOCS/SSI) Family Genes encode cytokine-specific-inducible negative feedback regulators that function downstream of cytokine receptors to attenuate signal transduction. Suppressor of Cytokine Signaling Proteins contain SH2 and SOCS BOX domains and are implicated, through SOCS box binding, in ubiquitin-dependent protein degradation. SOCS proteins interact with multiple tyrosine kinase activated signaling proteins and inhibit cytokine signal transduction by binding to tyrosine kinase receptors. SOCS proteins regulate cell growth and survival, placental development, hematopoiesis, and T-cell allergic responses. (NCI) ( NCI )] (UMLS (NCI) C1336533) Cytokine-Induced STAT Inhibitor Family Gene;
SOCS Family Gene;
SSI Family Gene;
STAT-Induced STAT Inhibitor Family Gene;
Suppressor of Cytokine Signaling Family Gene =Gene or Genome ;
|
- 111. CIRCADIAN RHYM OTH DIS
- [ ] (UMLS (ICD9CM) C1561878) Circadian rhythm sleep disorder in conditions classified elsewhere;
=Disease or Syndrome | - 161. CIS Family Protein
- [Encoded by Suppressor of Cytokine Signaling (SOCS/SSI) Family Genes, Suppressor of Cytokine Signaling Family Proteins are cytokine-specific-inducible negative feedback regulators that function downstream of cytokine receptors to attenuate signal transduction. Containing SH2 and SOCS BOX domains, SOCS proteins are implicated, through SOCS box binding, in ubiquitin-dependent protein degradation. SOCS proteins interact with multiple tyrosine kinase activated signaling proteins and inhibit cytokine signal transduction by binding to tyrosine kinase receptors. SOCS proteins regulate cell growth and survival, placental development, hematopoiesis, and T-cell allergic responses. (NCI) ( NCI )] (UMLS (NCI) C1336534) Cytokine-Induced STAT Inhibitor Family Protein;
SOCS Family Protein;
SSI Family Protein;
STAT-Induced STAT Inhibitor Family Protein;
Suppressor of Cytokine Signaling Family Protein =Amino Acid, Peptide, or Protein ;
|
- 112. CIRCADIAN RHYM SLEEP NEC
- [ ] (UMLS (ICD9CM) C1561879) Other circadian rhythm sleep disorder;
=Disease or Syndrome | - 162. cis trans isomerization
- [isomerism that occurs in compounds with double bonds; since the double bond is rigid, atoms and functional groups are not free to rotate; the cis isomer has the two groups on the same side of the double bond, the trans isomer on opposite sides. ( CSP )] (UMLS (CSP) C0596342) =Molecular Function; Spatial Concept =stereochemistry;
|
- 113. CIRCADIAN RHYM SLEEP NOS
- [ ] (UMLS (ICD9CM) C1561871) Circadian rhythm sleep disorder, unspecified;
=Disease or Syndrome | - 163. Cis-1,1-diamino-methylcyclohexane sulfato-platinum
- [A synthetic derivative of cyclohexane sulfatoplatinum with antineoplastic properties. Spiroplatin induces DNA cross-links, thereby inhibiting DNA replication and RNA and protein synthesis. Similar to other platinum compounds, this agent has been shown to be mutagenic and carcinogenic. (NCI04) ( NCI )] (UMLS (NCI) C0075022) =Organic Chemical; Pharmacologic Substance ;
|
- 114. CIRCADIAN RHYM-FREE RUN
- [ ] (UMLS (ICD9CM) C1561875) Circadian rhythm sleep disorder, free-running type;
=Disease or Syndrome | - 164. cis-1,2,3,5-trans-4,6-Cyclohexanehexol
- [cyclic sugar alcohol, the fully hydroxylated derivative of cyclohexane, occurring naturally in a variety of stereoisomers, most commonly, the myo-isomer, myoinositol, a member of the vitamin B complex and a component of phosphatidylinositols. ( CSP )] (UMLS (NCI) C0021547) =Carbohydrate; Pharmacologic Substance; Vitamin =sugar alcohol;
[VT100] VITAMIN B;
Inactive Ingredient Preparations;
=inositol phosphate;
Lecithin 420 MG Oral Capsule;
NURSOY LIQUID;
INOSITOL 50 MG;
INOSITOL 0.83 %;
INOSITOL 111 MG;
INOSITOL 111.33 MG;
INOSITOL 19 MG/240ML;
INOSITOL 200 MG/240ML;
INOSITOL 250 MG/L;
INOSITOL 60 MG/240ML |
- 115. CIRCADIAN RHYM-IRREG SLP
- [ ] (UMLS (ICD9CM) C1561874) Circadian rhythm sleep disorder, irregular sleep-wake type;
=Disease or Syndrome | - 165. Cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
- [1-acetyl-4-(2,4-dichlorophenyl-2-imidazolylmethyl- 1,3- dioxolanylmethoxyphenyl) piperazine; broad spectrum, oral antifungal. ( CSP )] (UMLS (NCI) C0022625) =Organic Chemical; Pharmacologic Substance =[AM700] ANTIFUNGALS;
imidazole;
Piperazines;
[DE102] ANTIFUNGAL, TOPICAL =KETOCONAZOLE 200 MG;
KETOCONAZOLE 2 %;
KETOCONAZOLE 1 % |
- 116. circadian rhythm
- [rhythmic recurrences of certain phenomena in living organisms occurring at about the same time of day, i.e., on a 24 hour cycle. ( CSP )] (UMLS (CSP) C0008810) =Organism Function ;
=bioperiodicity;
| - 166. cis-4-Amino-5-Chloro-N-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-Anisamide
- [cis-4-amino-5-chloro-N-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-anisamide; peristaltic stimulant under clinical evaluation for constipation, gastroparesis, intestinal pseudoobstruction, and other GI motility disorders. ( CSP )] (UMLS (NCI) C0072916) =Organic Chemical; Pharmacologic Substance =Benzamides;
[GA000] GASTROINTESTINAL MEDICATIONS;
piperidine;
Piperidines;
phenylamide;
[GA900] GASTRIC MEDICATIONS, OTHER =Cisapride 1 MG/ML;
CISAPRIDE 10 MG;
CISAPRIDE 20 MG |
- 117. Circadian rhythm sleep disorder
- [Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel (e.g., JET LAG SYNDROME), shift work, or other causes. ( MSH )] (UMLS (ICD9CM) C0877792) Sleep Disorders, Circadian Rhythm;
=Pathologic Function ;
=occupational disease;
Chronobiology Disorders;
dyssomnia;
=Jet Lag Syndrome;
| - 167. CISH
- [This gene plays a role in cellular signaling. ( NCI )] (UMLS (NCI) C1332762) CISH Gene;
Cytokine-Inducible SH2-Containing Protein Gene =Gene or Genome |
- 118. Circadian rhythm sleep disorder of nonorganic origin
- [ ] (UMLS (ICD9CM) C1561844) NONORGANIC CIRCADIAN RHY;
=Mental or Behavioral Dysfunction | - 168. Cisplatin Liposomal
- [A synthetic formulation in which the antineoplastic agent cisplatin is encapsulated in lipids. Cisplatin liposomal consists of small aggregates of cisplatin covered by a single lipid bilayer. Encasement in liposomes improves cisplatin's tumor bioavailability and toxicity profile. Liposomal encapsulation does not affect the pharmacological properties of cisplatin directly. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition. (NCI04) ( NCI )] (UMLS (NCI) C0796445) Cisplatin, Liposomal;
Liposomal Cisplatin;
=Pharmacologic Substance; Inorganic Chemical |
- 119. Circadian rhythm sleep disorder, jet lag type
- [ ] (UMLS (ICD9CM) C1561876) CIRCADIAN RHYTHM-JETLAG;
=Disease or Syndrome | - 169. Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Thalidomide
- [A chemotherapy combination used in the treatment of cancers such as multiple myeloma and consisting of dexamethasone (antiinflammatory), cisplatin, Dexamethasone, cyclophosphamide, etoposide (cytostatic) and thalidomide (antiangiogenic). (NCI04) ( NCI )] (UMLS (NCI) C0879504) =Therapeutic or Preventive Procedure ;
|
- 120. circle
- [2 [pi].rad ( HL7V3.0 )] (UMLS (HL7) C1553015) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens ◊ [A circle defined by two (column,row) pairs. The first point is the center of the circle and the second point is a point on the perimeter of the circle. ( HL7V3.0 )] (UMLS (HL7) C1553439) Idea or Concept ROIOverlayShape; | - 170. Cisplatin/Cyclophosphamide/Etoposide/Mafosfamide/Vincristine
- (UMLS (NCI) C0879463) =Therapeutic or Preventive Procedure ;
|
- 121. Circle
- [List bullets are hollow discs ( HL7V3.0 )] (UMLS (HL7) C1697268) =Intellectual Product =Unordered List Style;
| - 171. Cisplatin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine
- (UMLS (NCI) C0935684) =Therapeutic or Preventive Procedure
|
- 122. Circle
- [A ring-shaped structure with every point equidistant from the center. ( NCI )] (UMLS (NCI) C1282913) Circular;
=Spatial Concept | - 172. Cisplatin/Cytarabine/Dexamethasone/Rituximab
- (UMLS (NCI) C0879479) =Therapeutic or Preventive Procedure ;
|
- 123. Circle Native Community
- (UMLS (HL7) C1550838) =Population Group =NativeEntityAlaska;
| - 173. Cisplatin/Cytarabine/Etoposide/Ifosfamide/Yttrium Y 90 Humanized Epratuzumab
- (UMLS (NCI) C0879366) =Therapeutic or Preventive Procedure ;
|
- 124. circular dichroism
- [planar polarization converts to eliptic polarization when plane polarized light travels through an optically active medium. ( CSP )] (UMLS (CSP) C0008813) =Laboratory Procedure; Natural Phenomenon or Process =spectrometry;
dichroism =circular magnetic dichroism;
| - 174. Cisplatin/Cytarabine/Methylprednisolone/Pixantrone
- (UMLS (NCI) C1327856) =Therapeutic or Preventive Procedure
|
- 125. circular DNA
- [covalently closed DNA ring found in bacteria, many viruses, mitochondria, plastids, and plasmids; small circular DNA has also been observed in a number of eukaryotic organisms. ( CSP )] (UMLS (CSP) C0012925) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =deoxyribonucleic acid;
=Plasmid | - 175. Cisplatin/Cytarabine/Methylprednisolone/Pixantrone/Rituximab
- (UMLS (NCI) C1328021) =Therapeutic or Preventive Procedure; ;
|
- 126. Circular Fold
- (UMLS (NCI) C0227265) =Body Part, Organ, or Organ Component
| - 176. Cisplatin/Dacarbazine/Doxorubicin/Mitomycin/Sargramostim
- (UMLS (NCI) C1134619) =Therapeutic or Preventive Procedure ;
|
- 127. circular helicase dependent amplification (c-hda)
- [ ] (UMLS (CSP) C1655923) =Molecular Biology Research Technique ;
| - 177. Cisplatin/Dexamethasone/Gemcitabine
- (UMLS (NCI) C0935814) =Therapeutic or Preventive Procedure
|
- 128. circular magnetic dichroism
- [magnetically induced circular dichroism is the differential absorption of left and right circularly polarized light in the presence of a magnetic field; measurements are made by taking a circular dichroism, or CD measurement, with the magnetization oriented in the positive sense, and then a CD measurement with the magnetization oriented in the negative sense; the two signals are then subtracted. ( CSP )] (UMLS (CSP) C0596341) =Natural Phenomenon or Process ;
=circular dichroism;
| - 178. Cisplatin/Dexrazoxane/Doxorubicin
- (UMLS (NCI) C0796699) =Therapeutic or Preventive Procedure ;
|
- 129. circular mil
- [1 [pi]/4.[mil_i]2 ( HL7V3.0 )] (UMLS (HL7) C1552913) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 179. Cisplatin/Dimesna/Docetaxel
- (UMLS (NCI) C1328145) =Therapeutic or Preventive Procedure ;
|
- 130. Circular Sulcus
- (UMLS (NCI) C0228258) =Body Space or Junction
| - 180. Cisplatin/Docetaxel/Trastuzumab
- (UMLS (NCI) C0935899) =Therapeutic or Preventive Procedure
|
- 131. circulating cancer cell
- [ ] (UMLS (CSP) C0920441) =Cell
| - 181. Cisplatin/Doxorubicin Hydrochloride Liposome/Mitomycin
- (UMLS (NCI) C1327821) =Therapeutic or Preventive Procedure ;
|
- 132. circulating neoplastic cell
- [exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. ( CSP )] (UMLS (CSP) C0027625) =Cell =metastasis;
neoplastic cell | - 182. Cisplatin/Doxorubicin Hydrochloride Liposome/Paclitaxel
- (UMLS (NCI) C1327851) =Therapeutic or Preventive Procedure; ;
|
- 133. CIRCULATORY
- (UMLS (ICPC) C0497231) (CIRCULATORY; (194); (115); (116); (104); (105); (106); (108); (119); (133); (130); (122); (123)) =Functional Concept =International Classification of Primary Care; =Angina; arrhythmia; Cardiac Insufficiency; BIHOTZ PUTZALDIA EZ; aranyer; ASENTOON LIITTYVA MATALA VERENPAINE/HYPOTENSIO; BIRIKA EMBOLIA; BIHOTZ BIRIKAZKO KRONIKOA; Acuut reuma/reumatische hartziekte; Acc cerebrovascular/apoplejia; EXTRASISTOLEAK,EDOZEIN TIPO; acut myocardialis infarctus; Altre cardiop ischemiche/croniche; Atrial fibrillation and flutter; ADERBRACK PA BEN (EXKL S97); Altre malattie del cuore; batzeket baraglaim; Aangeboren afw hartvaatstelsel; Altre mal sistema circolatorio; BIOTZARI ESLEITURIKO MINA; dalyot mafriot o maxivot; Druck/Enge, dem Herz zugeschrieben; Altro dolore attr al circolo; dfikot lev; Altre anom/irreg batt cuore/polso; Angst voor hartaanval; Angst voor hoge bloeddruk; Angst and ziekte hartvaatstelsel; Altri sint cuore/sistema circ; Doen infecciosas ap circulatorio; cardiovascular cancer; billentyuhiba (nem meghat.); BIHOTZEKO PRESIO GORATUA HIPERTENTSIORIK GABE; Hipertensao nao complicada; BLTRSJUKDOM MED SKADOR PA MALORGAN; ARTERIOSKLEROS EXKL HJARTA/HJARNA; Altre ostruz arter/mal vasc perif; Diminuita capacita/menomazione; atmeneti agyi ischaemia (TIA); Arebetaendelse
| - 183. Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate/Trastuzumab
- (UMLS (NCI) C1134487) =Therapeutic or Preventive Procedure
|
- 134. CIRCULATORY ANOMALY NEC
- [ ] (UMLS (ICD9CM) C0478008) =Congenital Abnormality
| - 184. Cisplatin/Doxorubicin/Methotrexate/Trastuzumab
- (UMLS (NCI) C1134486) =Therapeutic or Preventive Procedure
|
- 135. CIRCULATORY ANOMALY NOS
- [ ] (UMLS (ICD9CM) C0478013) =Congenital Abnormality
| - 185. Cisplatin/Edotecarin
- (UMLS (NCI) C1328081) =Therapeutic or Preventive Procedure ;
|
- 136. circulatory assist
- [surgical support techniques that with pumping aids the natural activity of the heart. ( CSP )] (UMLS (CSP) C0004080) =Therapeutic or Preventive Procedure ;
| - 186. Cisplatin/Epoetin Alfa
- (UMLS (NCI) C0935875) =Therapeutic or Preventive Procedure ;
|
- 137. Circulatory Collapse
- [a profound hemodynamic and metabolic disturbance characterized by the failure of the circulatory system to maintain adequate perfusion of vital organs; causes inadequate delivery of nutrients and insufficient removal of cellular waste products to and from the tissues. ( CSP )] (UMLS (NCI) C0036974) =Pathologic Function =MOF syndrome;
Clinical Finding =Cardiogenic Shock;
Hemorrhagic Shock;
Septic shock;
spinal shock;
Shock syndrome (TSS), toxic;
Cardiogenic Shock;
Hemorrhagic Shock;
Septic shock;
Shock, Surgical;
Shock, Traumatic;
Sepsis Syndrome | - 187. Cisplatin/Erlotinib
- (UMLS (NCI) C1134575) =Therapeutic or Preventive Procedure
|
- 138. CIRCULATORY DISEASE NEC
- [ ] (UMLS (ICD9CM) C0155803) =Disease or Syndrome ;
| - 188. Cisplatin/Erlotinib/Etoposide
- (UMLS (NCI) C1327738) =Therapeutic or Preventive Procedure
|
- 139. CIRCULATORY DISEASE NOS
- [ ] (UMLS (ICD9CM) C0728936) DISEASES OF THE CIRCULATORY SYSTEM;
Unspecified circulatory system disorder =Disease or Syndrome | - 189. Cisplatin/Etoposide/Ifosfamide/Prednisolone
- (UMLS (NCI) C1134490) =Therapeutic or Preventive Procedure
|
- 140. Circulatory monitoring
- [ ] (UMLS (ICD9CM) C0161959) =Diagnostic Procedure; Therapeutic or Preventive Procedure
| - 190. Cisplatin/Etoposide/Irinotecan
- (UMLS (NCI) C1327936) =Therapeutic or Preventive Procedure; ;
|
- 141. circumcision
- [Excision of the prepuce of the penis (FORESKIN) or part of it. ( MSH )] (UMLS (CSP) C0008819) =Therapeutic or Preventive Procedure ;
| - 191. Cisplatin/Etoposide/Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine
- (UMLS (NCI) C1327759) =Therapeutic or Preventive Procedure; ;
|
- 142. Circumcision Site
- (UMLS (HL7) C1550231) =Body Location or Region =Body Part;
| - 192. Cisplatin/Etoposide/Tirapazamine
- (UMLS (NCI) C0935711) =Therapeutic or Preventive Procedure
|
- 143. Circumcision _ Newborn
- (UMLS (HL7) C1548836) =Health Care Activity =Consent Type;
| - 193. Cisplatin/Etoposide/Topotecan
- (UMLS (NCI) C1327935) =Therapeutic or Preventive Procedure; ;
|
- 144. Circumference
- [The length of the closed curve of a circle; the size of something as given by the distance around it. ( NCI )] (UMLS (NCI) C0332520) =Quantitative Concept
| - 194. Cisplatin/Fenretinide/Paclitaxel
- (UMLS (NCI) C0879503) =Therapeutic or Preventive Procedure ;
|
- 145. Circumflex Branch of Left Coronary Artery
- (UMLS (NCI) C0226037) =Body Part, Organ, or Organ Component
| - 195. Cisplatin/Filgrastim/Fluorouracil/Paclitaxel
- (UMLS (NCI) C1327998) =Therapeutic or Preventive Procedure ;
|
- 146. Circumflex Iliac Artery
- (UMLS (NCI) C0447101) =Body Part, Organ, or Organ Component
| - 196. Cisplatin/Flavopiridol/Irinotecan
- (UMLS (NCI) C1327785) =Therapeutic or Preventive Procedure ;
|
- 147. Circumpapillary dystrophy of choroid, partial
- [ ] (UMLS (ICD9CM) C0154895) =Disease or Syndrome
| - 197. Cisplatin/Flavopiridol/Paclitaxel
- (UMLS (NCI) C0796644) =Therapeutic or Preventive Procedure
|
- 148. Circumpapillary dystrophy of choroid, total
- [ ] (UMLS (ICD9CM) C0154896) =Disease or Syndrome
| - 198. Cisplatin/Fluorouracil/G17DT
- (UMLS (NCI) C0935890) =Therapeutic or Preventive Procedure
|
- 149. CIRCUMSCRI LABYRINTHITIS
- [ ] (UMLS (ICD9CM) C0155505) =Disease or Syndrome ;
| - 199. Cisplatin/Fluorouracil/Gemcitabine
- (UMLS (NCI) C0879268) =Therapeutic or Preventive Procedure
|
- 150. CIRCUMSCRIBE SCLERODERMA
- [A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules. ( MSH )] (UMLS (ICD9CM) C0036420) =Disease or Syndrome; Anatomical Abnormality =Connective Tissue Disease;
Cutaneous Disorder | - 200. Cisplatin/Fluorouracil/Irinotecan
- (UMLS (NCI) C0879498) =Therapeutic or Preventive Procedure ;
|
home
